SCHEMBL6273385

SCHEMBL6273385

CC1CCC(C(=O)O)CC1.CC1CCC(C(N)=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
PLG P00747 1/20 0.45
PLAT P00750 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.41
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
TSHR P16473 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRE P78334 1/20 0.39
PMP22 Q01453 1/20 0.39
GABRA6 Q16445 1/20 0.39
GABRG1 Q8N1C3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13363702 0.91 SMN1; SMN2 (0.46) SMN1; SMN2EPHX1GAAKDM4EMAPT
SCHEMBL1690354 0.91 SMN1; SMN2 (0.46) SMN1; SMN2EPHX1GAAKDM4EMAPT
SCHEMBL6908741 0.91 LMNA (0.46) LMNAPLGPLATSMN1; SMN2GABRP
SCHEMBL2215054 0.91 SMN1; SMN2 (0.46) SMN1; SMN2EPHX1GAAKDM4EMAPT
SCHEMBL1741318 0.88 LMNA (0.54) LMNAPLGPLATSMN1; SMN2GABRP
SCHEMBL7817617 0.88 LMNA (0.54) LMNAPLGPLATSMN1; SMN2GABRP
SCHEMBL15139817 0.88 LMNA (0.54) LMNAPLGPLATSMN1; SMN2GABRP
SCHEMBL135662 0.88 LMNA (0.48) LMNAPLGPLATSMN1; SMN2GABRP
SCHEMBL135660 0.88 LMNA (0.48) LMNAPLGPLATSMN1; SMN2GABRP
SCHEMBL265529 0.88 LMNA (0.48) LMNAPLGPLATSMN1; SMN2GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606244-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT Abbott Laboratories (US) 2005-12-21 EP disclosed
WO-2004037769-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT ABBOTT LABORATORIES (US) 2004-05-06 WO disclosed